http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182903-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea5ddac9cae108a5f80101c3f50a351
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0521d2bd5306a691502761137b4d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2811a02272ea4c10734d14d1ed1ffc81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cb50e1da1c3c72cd00f8d221c40088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a986c11e3f947f862c5bb5a2283763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30749ad09a156d7056d9043c4baa9bbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fed4153943ef4639f5fd96d4c479feb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75dfb10250abdbc9c98ad2e51d873bc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c020e26140687ccf71aecd7926b70185
publicationDate 2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021182903-A1
titleOfInvention Composition comprising pi3 kinase inhibitor and btk inhibitor
abstract The present invention provides a composition comprising: a compound represented by chemical formula 1, an isomer thereof, or a pharmaceutically acceptable salt thereof; and a BTK inhibitor. The composition of the present invention exhibits an excellent lymphatic tumor treatment effect.
priorityDate 2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160093062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019183226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016209961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160150006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170074381-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226583466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466831205

Total number of triples: 41.